Novo Nordisk President and CEO Mike Doustdar joins ‘Mornings with Maria’ to discuss the launch of the first GLP-1 weight-loss pill in the U.S., the lawsuit against Hims & Hers and talks with the Trump administration on drug pricing. GLP-1 weight-loss drugs are now the focus of a heated legal battle, with a leading drugmaker […]
